Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators
US9556188B2 · kind B2 · utility
24Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2015 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is fused heterocyclic compounds of formula (I), and salts thereof, compositions thereof, and methods of use therefor. In particular, disclosed herein are certain fused heterocyclic compounds that can be useful for inhibiting protein kinase, including Bruton's tyrosine kinase (Btk), and for treating disorders mediated thereby.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.